Kestra Medical Technologies today announced the presentation of new real-world data for its Assure wearable cardioverter defibrillator (WCD). The company shared findings from an abstract examining outcomes in a nonprofit, community-based medical center using an advanced practice provider (APP)-driven protocol for WCD therapy. Kestra says it represents one of the first analyses of its kind. […]
Kestra Medical Technologies
Wearable defibrillator maker Kestra Medical goes public with upsized $202M IPO
Kestra Medical Technologies (Nasdaq:KMTS) began trading on the Nasdaq market following an upsized initial public offering (IPO). The maker of the Assure wearable cardioverter defibrillator (WCD) system priced nearly 12 million shares at $17 per share. Underwriters have a 30-day over-allotment option to purchase up to nearly 1.8 million additional common shares at the offering […]
Kestra Medical picks former Axonics exec as new CCO
Kestra Medical Technologies announced today that it appointed Al Ford as its new chief commercial officer (CCO). As CCO, Ford now holds responsibility for advancing sales strategy and leading the Kestra commercial team. His appointment comes at a critical juncture, as the wearable medical device maker recently filed for an IPO. Kirkland, Washington-based Kestra develops the […]
Wearable defibrillator maker Kestra Medical files for IPO
Kestra Medical recently filed a form S-1 to confirm its intent to go public through an initial public offering (IPO). In a filing fee schedule listed on the S-1, the Kirkland, Washington–based wearable cardioverter defibrillator (WCD) company set its sights on raising roughly $100 million. This latest move from Kestra could provide yet another sign […]
Kestra Medical raises $196M to support wearable cardioverter defibrillator
Kestra Medical Technologies announced today that it raised $196 million in an oversubscribed financing round. The company plans to use the funds to support its modern wearable cardioverter defibrillator (WCD) technology. Its Assure WCD system received FDA approval in 2021. Andera Partners, Ally Bridge Group, Longitude Capital and Omega Funds co-led the financing. New investors, […]
FDA approves Kestra Medical Technologies’s wearable cardioverter defibrillator
Kestra Medical Technologies announced today that it received FDA approval for its Assure wearable cardioverter defibrillator (WCD) system. Kirkland, Wash.-based Kestra designed its Assure WCD system as a modern, comfortable wearable device with integrated sensors, a cardiac rhythm monitor and a miniaturized automated external defibrillator, according to a news release. The system, designed to protect […]
